🚀 VC round data is live in beta, check it out!
Bioextrax Valuation Multiples
Discover revenue and EBITDA valuation multiples for Bioextrax and similar public comparables like Ocean GeoLoop, Ambipar Emergency, EcoUp, GEL and more.
Bioextrax Overview
About Bioextrax
Bioextrax AB is engaged in the development and production of bio-plastics granules, organic hydrolyzed protein, and keratin fibers.
Founded
2014
HQ
Employees
N/A
Website
Financials (LTM)
EV
$13M
Bioextrax Financials
Bioextrax reported last 12-month revenue of $129K and negative EBITDA of ($2M).
In the same LTM period, Bioextrax generated $1K in gross profit, ($2M) in EBITDA losses, and had net loss of ($2M).
Revenue (LTM)
Bioextrax P&L
In the most recent fiscal year, Bioextrax reported revenue of $83K and EBITDA of ($2M).
Bioextrax expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $129K | XXX | $83K | XXX | XXX | XXX |
| Gross Profit | $1K | XXX | ($54K) | XXX | XXX | XXX |
| Gross Margin | 1% | XXX | (64%) | XXX | XXX | XXX |
| EBITDA | ($2M) | XXX | ($2M) | XXX | XXX | XXX |
| EBITDA Margin | (1416%) | XXX | (2132%) | XXX | XXX | XXX |
| EBIT Margin | (1510%) | XXX | (2294%) | XXX | XXX | XXX |
| Net Profit | ($2M) | XXX | ($2M) | XXX | XXX | XXX |
| Net Margin | (1502%) | XXX | (2277%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Bioextrax Stock Performance
Bioextrax has current market cap of $13M, and enterprise value of $13M.
Market Cap Evolution
Bioextrax's stock price is $0.28.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $13M | $13M | -10.7% | XXX | XXX | XXX | $-0.04 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBioextrax Valuation Multiples
Bioextrax trades at 100.4x EV/Revenue multiple, and (7.1x) EV/EBITDA.
EV / Revenue (LTM)
Bioextrax Financial Valuation Multiples
As of April 11, 2026, Bioextrax has market cap of $13M and EV of $13M.
Equity research analysts estimate Bioextrax's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Bioextrax has a P/E ratio of (6.9x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $13M | XXX | $13M | XXX | XXX | XXX |
| EV (current) | $13M | XXX | $13M | XXX | XXX | XXX |
| EV/Revenue | 100.4x | XXX | 155.4x | XXX | XXX | XXX |
| EV/EBITDA | (7.1x) | XXX | (7.3x) | XXX | XXX | XXX |
| EV/EBIT | (6.6x) | XXX | (6.8x) | XXX | XXX | XXX |
| EV/Gross Profit | 8905.8x | XXX | (241.1x) | XXX | XXX | XXX |
| P/E | (6.9x) | XXX | (7.0x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (4.6x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Bioextrax Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Bioextrax Margins & Growth Rates
Bioextrax's revenue in the last 12 month grew by 179%.
Bioextrax's rule of 40 is (509%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Bioextrax's rule of X is (197%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Bioextrax Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 179% | XXX | 200% | XXX | XXX | XXX |
| EBITDA Margin | (1416%) | XXX | (2132%) | XXX | XXX | XXX |
| EBITDA Growth | (6%) | XXX | 1% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (509%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | (197%) | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 2230% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Bioextrax Public Comps
See public comps and valuation multiples for other Waste & Environmental Services comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Ocean GeoLoop | XXX | XXX | XXX | XXX | XXX | XXX |
| Ambipar Emergency | XXX | XXX | XXX | XXX | XXX | XXX |
| EcoUp | XXX | XXX | XXX | XXX | XXX | XXX |
| GEL | XXX | XXX | XXX | XXX | XXX | XXX |
| Axolot Solutions Holding | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Bioextrax M&A Activity
Bioextrax acquired XXX companies to date.
Last acquisition by Bioextrax was on XXXXXXXX, XXXXX. Bioextrax acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Bioextrax
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialBioextrax Investment Activity
Bioextrax invested in XXX companies to date.
Bioextrax made its latest investment on XXXXXXXX, XXXXX. Bioextrax invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Bioextrax
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Bioextrax
| When was Bioextrax founded? | Bioextrax was founded in 2014. |
| Where is Bioextrax headquartered? | Bioextrax is headquartered in Sweden. |
| Is Bioextrax publicly listed? | Yes, Bioextrax is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Bioextrax? | Bioextrax trades under BIOEX ticker. |
| When did Bioextrax go public? | Bioextrax went public in 2022. |
| Who are competitors of Bioextrax? | Bioextrax main competitors are Ocean GeoLoop, Ambipar Emergency, EcoUp, GEL. |
| What is the current market cap of Bioextrax? | Bioextrax's current market cap is $13M. |
| What is the current revenue of Bioextrax? | Bioextrax's last 12 months revenue is $129K. |
| What is the current revenue growth of Bioextrax? | Bioextrax revenue growth (NTM/LTM) is 179%. |
| What is the current EV/Revenue multiple of Bioextrax? | Current revenue multiple of Bioextrax is 100.4x. |
| Is Bioextrax profitable? | No, Bioextrax is not profitable. |
| What is the current EBITDA of Bioextrax? | Bioextrax has negative EBITDA and is not profitable. |
| What is Bioextrax's EBITDA margin? | Bioextrax's last 12 months EBITDA margin is (1416%). |
| What is the current EV/EBITDA multiple of Bioextrax? | Current EBITDA multiple of Bioextrax is (7.1x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.